Xbrane Biopharma AB Financial Flexibility Index
Xbrane Biopharma AB financial flexibility index. Xbrane Biopharma AB (XBRANE) has a Financial Flexibility Index of -0.05x as of June 2026. Free cash flow of Skr-4.71 Million (operating CF Skr-4.82 Million minus capex Skr108.00K) represents 0% of total liabilities (Skr103.76 Million). See cash generation quality of Xbrane Biopharma AB to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Xbrane Biopharma AB (2013–2025)
Financial flexibility index of Xbrane Biopharma AB from 2013 to 2025. Historical Financial Flexibility Index trend for Xbrane Biopharma AB across 13 annual periods. Check XBRANE cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Xbrane Biopharma AB Financial Flexibility Index by Year (2013–2025)
Xbrane Biopharma AB financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Xbrane Biopharma AB. For the full cash flow conversion analysis, see Xbrane Biopharma AB (XBRANE) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | Skr-111.05 Million | Skr-250.69 Million | Skr110.97 Million | ▼ -678.5% |
| 2024 | -0.13x | Skr-81.48 Million | Skr-133.73 Million | Skr633.89 Million | ▲ +84.1% |
| 2023 | -0.81x | Skr-389.91 Million | Skr-406.68 Million | Skr482.17 Million | ▼ -60.5% |
| 2022 | -0.50x | Skr-133.79 Million | Skr-193.92 Million | Skr265.63 Million | ▲ +9.1% |
| 2021 | -0.55x | Skr-142.26 Million | Skr-219.61 Million | Skr256.69 Million | ▲ +51.3% |
| 2020 | -1.14x | Skr-234.55 Million | Skr-238.41 Million | Skr206.06 Million | ▼ -19.4% |
| 2019 | -0.95x | Skr-147.40 Million | Skr-148.59 Million | Skr154.62 Million | ▼ -435.1% |
| 2018 | 0.28x | Skr48.30 Million | Skr46.71 Million | Skr169.81 Million | ▲ +119.2% |
| 2017 | -1.49x | Skr-33.50 Million | Skr-36.85 Million | Skr22.55 Million | ▲ +41.3% |
| 2016 | -2.53x | Skr-27.34 Million | Skr-39.43 Million | Skr10.81 Million | ▼ -526.0% |
| 2015 | -0.40x | Skr-11.24 Million | Skr-12.39 Million | Skr27.82 Million | ▲ +93.6% |
| 2014 | -6.35x | Skr-2.48 Million | Skr-2.67 Million | Skr390.70K | ▼ -46.1% |
| 2013 | -4.35x | Skr-2.20 Million | Skr-2.20 Million | Skr505.44K | — |